Wyden says Medicaid may have "grossly" overpaid for EpiPens By: Portland Business Journal via Business Journals September 02, 2016 at 16:55 PM EDT Wyden contends Mylan may have misclassified the EpiPen as a generic device under the Medicaid program, thus reducing the rebates it pays. Read More >>
